BioCentury
ARTICLE | Financial News

Amazentis raises CHF8.4M, begins two Phase II trials

March 23, 2018 6:42 PM UTC

Aging company Amazentis S.A. (Lausanne, Switzerland) raised CHF8.4 million ($8.8 million) in a series C round from an undisclosed new investor and existing investors...

BCIQ Company Profiles

Amazentis S.A.